Nucleoside Metabolic Inhibitor
Where is Cytarabine made?
5 companies sell it under their own name. Their labels name 4 factories in India, the United States and China.
India 2United States 1China 1
Companies and their factories
| Company on the label | Factory | Where | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi, LLC100 mg per 1 mL · NDC 63323-120 | Fresenius Kabi USA, LLCMakes it and tests it | Melrose Park, IL, United States | Problems found, fixed voluntarilyAug 2023 |
| Gland Pharma Limited20 mg per 1 mL, 100 mg per 1 mL · NDC 68083-337, 68083-343 | Gland Pharma LimitedMakes it and tests it | Visakhapatnam, India | No problems foundJul 2023 |
| Hospira, Inc.20 mg per 1 mL, 100 mg per 1 mL · NDC 61703-319, 61703-155, 61703-304 +2 | Zydus Hospira Oncology Private LimitedMakes it, tests it, packages it and labels it | Ahmedabad, India | Problems found, fixed voluntarilyJun 2023 |
| Meitheal Pharmaceuticals Inc.2 g per 20 mL, 20 mg per 1 mL · NDC 71288-109, 71288-108, 71288-168 +1 | Kindos Pharmaceuticals Co., Ltd.Makes it | Chengdu, China | Problems found, fixed voluntarilyJul 2024 |
| Sagent Pharmaceuticals20 mg per 1 mL, 100 mg per 1 mL · NDC 25021-223, 25021-229 | The label doesn't name the factory. Plants this company names for other drugs | ||
Recalls
- Jun 27, 2012 · Class II · Hospira Inc.
The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product …
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.